Biodegradable ocular implants

Cytomegalovirus (CMV) retinitis is the most common ocular infection in patients with Acquired Immune Deficiency Syndrome (AIDS), occurring in 15%-40% of AIDS patients. It will cause blindness in 3 to 6 months if left untreated. The available mode of treatments ranges from intravenous to implants for...

Full description

Saved in:
Bibliographic Details
Main Author: Ooi, Chui Ping
Other Authors: School of Chemical and Biomedical Engineering
Format: Research Report
Published: 2008
Subjects:
Online Access:http://hdl.handle.net/10356/2192
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
id sg-ntu-dr.10356-2192
record_format dspace
spelling sg-ntu-dr.10356-21922023-03-03T15:30:37Z Biodegradable ocular implants Ooi, Chui Ping School of Chemical and Biomedical Engineering DRNTU::Science::Medicine::Biomedical engineering Cytomegalovirus (CMV) retinitis is the most common ocular infection in patients with Acquired Immune Deficiency Syndrome (AIDS), occurring in 15%-40% of AIDS patients. It will cause blindness in 3 to 6 months if left untreated. The available mode of treatments ranges from intravenous to implants for localised drug delivery. However, several problems have been associated with these treatments and a sustained-release biodegradable device is needed to decrease these risks and produce a longer therapeutic effect. 2008-09-16T06:42:54Z 2008-09-16T06:42:54Z 2001 2001 Research Report http://hdl.handle.net/10356/2192 Nanyang Technological University application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
topic DRNTU::Science::Medicine::Biomedical engineering
spellingShingle DRNTU::Science::Medicine::Biomedical engineering
Ooi, Chui Ping
Biodegradable ocular implants
description Cytomegalovirus (CMV) retinitis is the most common ocular infection in patients with Acquired Immune Deficiency Syndrome (AIDS), occurring in 15%-40% of AIDS patients. It will cause blindness in 3 to 6 months if left untreated. The available mode of treatments ranges from intravenous to implants for localised drug delivery. However, several problems have been associated with these treatments and a sustained-release biodegradable device is needed to decrease these risks and produce a longer therapeutic effect.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Ooi, Chui Ping
format Research Report
author Ooi, Chui Ping
author_sort Ooi, Chui Ping
title Biodegradable ocular implants
title_short Biodegradable ocular implants
title_full Biodegradable ocular implants
title_fullStr Biodegradable ocular implants
title_full_unstemmed Biodegradable ocular implants
title_sort biodegradable ocular implants
publishDate 2008
url http://hdl.handle.net/10356/2192
_version_ 1759856156401991680